These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 36968588)
1. Epigenetics and immune cells in medulloblastoma. Gorini F; Miceli M; de Antonellis P; Amente S; Zollo M; Ferrucci V Front Genet; 2023; 14():1135404. PubMed ID: 36968588 [TBL] [Abstract][Full Text] [Related]
2. Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors. Kurdi M; Mulla N; Malibary H; Bamaga AK; Fadul MM; Faizo E; Hakamy S; Baeesa S World J Clin Oncol; 2023 Mar; 14(3):117-130. PubMed ID: 37009528 [TBL] [Abstract][Full Text] [Related]
3. Immune cell infiltration and cytokine secretion analysis reveal a non-inflammatory microenvironment of medulloblastoma. Diao S; Gu C; Zhang H; Yu C Oncol Lett; 2020 Dec; 20(6):397. PubMed ID: 33193857 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy. Audi ZF; Saker Z; Rizk M; Harati H; Fares Y; Bahmad HF; Nabha SM Curr Treat Options Oncol; 2021 Jul; 22(9):83. PubMed ID: 34328587 [TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma epigenetics and the path to clinical innovation. Haltom AR; Toll SA; Cheng D; Maegawa S; Gopalakrishnan V; Khatua S J Neurooncol; 2020 Oct; 150(1):35-46. PubMed ID: 32816225 [TBL] [Abstract][Full Text] [Related]
7. Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups. Robbins CJ; Bou-Dargham MJ; Sanchez K; Rosen MC; Sang QA J Cancer; 2018; 9(24):4596-4610. PubMed ID: 30588243 [TBL] [Abstract][Full Text] [Related]
8. Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond. Garcia-Lopez J; Kumar R; Smith KS; Northcott PA Trends Genet; 2021 Mar; 37(3):235-250. PubMed ID: 33272592 [TBL] [Abstract][Full Text] [Related]
9. Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children. Wu KS; Jian TY; Sung SY; Hsieh CL; Huang MH; Fang CL; Wong TT; Lin YL Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563678 [TBL] [Abstract][Full Text] [Related]
10. Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137. Wang J; Sui Y; Li Q; Zhao Y; Dong X; Yang J; Liang Z; Han Y; Tang Y; Ma J Cell Death Dis; 2020 Dec; 11(12):1029. PubMed ID: 33268769 [TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma. Lian H; Han YP; Zhang YC; Zhao Y; Yan S; Li QF; Wang BC; Wang JJ; Meng W; Yang J; Wang QH; Mao WW; Ma J Mol Oncol; 2019 Oct; 13(10):2227-2245. PubMed ID: 31385424 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. Garzia L; Andolfo I; Cusanelli E; Marino N; Petrosino G; De Martino D; Esposito V; Galeone A; Navas L; Esposito S; Gargiulo S; Fattet S; Donofrio V; Cinalli G; Brunetti A; Vecchio LD; Northcott PA; Delattre O; Taylor MD; Iolascon A; Zollo M PLoS One; 2009; 4(3):e4998. PubMed ID: 19308264 [TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: Molecular understanding, treatment evolution, and new developments. Liu X; Ding C; Tan W; Zhang A Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673 [TBL] [Abstract][Full Text] [Related]
14. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma. Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157 [TBL] [Abstract][Full Text] [Related]
15. Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics. Batora NV; Sturm D; Jones DT; Kool M; Pfister SM; Northcott PA Neuroscience; 2014 Apr; 264():171-85. PubMed ID: 23876321 [TBL] [Abstract][Full Text] [Related]
17. Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics. García-Domínguez DJ; Hontecillas-Prieto L; Palazón-Carrión N; Jiménez-Cortegana C; Sánchez-Margalet V; de la Cruz-Merino L Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326620 [TBL] [Abstract][Full Text] [Related]
18. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma. Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257 [TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma stem cells: where development and cancer cross pathways. Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK Pediatr Res; 2012 Apr; 71(4 Pt 2):516-22. PubMed ID: 22430388 [TBL] [Abstract][Full Text] [Related]
20. Calcium Signalling in Medulloblastoma: An In Silico Analysis of the Expression of Calcium Regulating Genes in Patient Samples. Maklad A; Sedeeq M; Milevskiy MJG; Azimi I Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]